Medication info
Elpidogrel Tablets (Clopidogrel Sulfate)

Elpidogrel Tablets (Clopidogrel Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Mirae Bio Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201307935 · Approved 2013.06.28 · Insurance code 657502360

Summary

Main use
Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. Patients with ischemic stroke, myocardial infarction, or peripheral arterial disease should take clopidogrel 75 mg orally once daily. 2. Patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction) should start treatment on the day this drug is initiated with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. In this case, aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. Patients with atrial fibrillation should take this drug 75 mg orally once daily. In this case, aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This drug may be administered with or without food.

Ingredients

Manufacturer
Mirae Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-Q-wave myocardial infarction
  • cardiovascular anomalies
  • stroke
  • refractory ischemia
  • vascular risk factors
  • bleeding risk
  • atrial fibrillation
View approved original text

This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. Additionally, it helps improve atherosclerotic symptoms due to cardiovascular anomalies in patients with acute coronary syndrome who have undergone medication treatment, coronary intervention, or coronary artery bypass surgery, including reducing the risk of death, myocardial infarction, stroke, and refractory ischemia. Furthermore, it reduces the risk of atherosclerotic thrombosis such as stroke and thromboembolism among patients with atrial fibrillation who have vascular risk factors and in whom vitamin K antagonists are not suitable and bleeding risk is low. Therefore, this medication is used to alleviate important symptoms and reduce the risk of complications in various vascular-related diseases.

How to take

Adult dose

○ Adults 1. Patients with ischemic stroke, myocardial infarction, or peripheral arterial disease should take clopidogrel 75 mg orally once daily. 2. Patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction) should start treatment on the day this drug is initiated with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. In this case, aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. Patients with atrial fibrillation should take this drug 75 mg orally once daily. In this case, aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This drug may be administered with or without food.

Precautions

This medication is an antiplatelet drug that prevents the aggregation of platelets in the blood, thereby preventing thrombosis. The effect of this medication is manifested after it is converted to an active form in the body, which involves a specific enzyme (CYP2C19). Therefore, people genetically deficient in the function of this enzyme may experience reduced efficacy of the drug, and alternative treatment methods should be considered in such cases. Taking this medication together with specific drugs (e.g., drugs that activate CYP2C19) can increase the concentration of this medication and heighten the risk of bleeding, so co-administration should be avoided. Patients with a high risk of bleeding, severe liver damage, lactose intolerance, or those who are nursing should not use this medication. Patients at risk of bleeding must be especially cautious when using this medication and should immediately inform healthcare personnel of any bleeding symptoms that appear. If surgery is planned, this medication should be discontinued 5 to 7 days before surgery and resumed after hemostasis is achieved. This medication increases the risk of bleeding when used with other bleeding risk medications (aspirin, non-steroidal anti-inflammatory drugs, anticoagulants, etc.), so caution is necessary. During the use of this medication, if bleeding symptoms, skin rashes, or signs of infection occur, the patient should immediately consult a physician. If pregnant or nursing, the decision to take this medication should be made after consulting a physician, especially due to the potential for bleeding risk before delivery. Elderly patients and those with impaired kidney or liver function require dosage adjustments and close monitoring while using this medication. In case of overdose, the risk of bleeding may increase significantly, so patients should adhere to the prescribed dosage and inform healthcare personnel immediately of any abnormal symptoms. This medication should be kept out of the reach of children, and transferring it to other containers should be avoided.

Side effects

Hemorrhage, gastrointestinal bleeding, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, chest pain, traumatic injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, nausea, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, syncope, palpitations, weakness, fever, hernia, heart failure, atrial fibrillation, leg cramps, sensory impairment, neuralgia, sensory disturbance, vertigo, constipation, vomiting, increased liver enzymes, gout, hyperuricemia, increased non-protein nitrogen, arthritis, arthrosis, anxiety, insomnia, anemia, bloody stool, thrombocytopenia, pneumonia, sinusitis, eczema, skin ulcers, cystitis, cataract, conjunctivitis, reduced motor function, tremor, voice disorders, abnormal gait, hyperkinesia, ataxia, perceptual disturbances, insomnia, depression, memory loss, dysphoria, abnormal thoughts, abnormal behavior, weight loss, weight gain, facial flushing, rigidity, facial edema, purpura, bloody stool, thrombocytopenia, hypochromic anemia, leukemia, leukopenia, eosinophilia, menorrhagia, hemothorax, herpes zoster, erythematous rash, maculopapular rash, urticaria, renal dysfunction, acute renal failure, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, cholecystitis, hematemesis, spinal hematoma, allergic symptoms, ischemic necrosis, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, pulmonary hemorrhage, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, maculopapular rash, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, lichen planus, arthralgia, myalgia, glomerulopathy, gynecomastia, fever, reduced motor function, polydipsia, memory loss, abnormal thoughts, pollakiuria, arrhythmia, tremor, voice disorders, abnormal gait, hyperkinesia, ataxia, hiccups, dysphagia, tongue disorders, abnormal behavior, rigidity, visual disturbances, dry eyes, transient blindness, congestion, urinary disorders, uremia, hypoglycemia, bradycardia, tinnitus, contact dermatitis, elevated PSA, gynecomastia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is best to maintain a storage temperature between 1°C and 30°C room temperature. Proper storage will help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.